Targeting Wnt/β-Catenin Pathway for Drug Therapy

Chenglong Liu,Kohichi Takada,Di Zhu
DOI: https://doi.org/10.1016/j.medidd.2020.100066
2020-01-01
Medicine in Drug Discovery
Abstract:Abstract The Wnt/β-catenin signaling pathway, including canonical or noncanonical pathway, is a highly conserved pathway which can regulate cell proliferation, migration, differentiation, and apoptosis. The Wnt pathway has been shown to undergo aberrant activation in various cancers, particularly colorectal cancer. Wnt-targeted therapy attracted attention in a significant area of developmental therapeutics. Extensive efforts have been made to develop small-molecule drugs to inhibit the pathway for the treatment of various diseases. These small molecules disrupt protein-protein interactions in key parts of the pathway. Here, we review current indications for drug therapy and some problems in the treatment process that may be addressed in future investigations.
What problem does this paper attempt to address?